Launch of the Personalised Medicine Consortium (PMC) Fund

The Personalised Medicine Consortium (PMC) is pleased to announce the launch of a new funding programme named PMC FUND on 1st September 2014.


The PMC is keen to build new collaborations between clinicians and researchers from Luxembourg and to foster new synergies. To aid in this process, the three PMC-related institutions CRP-Santé, LCSB and IBBL have signed an agreement to develop the PMC FUND to ‘pump prime’ new initiatives.

The expectation is that the funding will be used to initiate new collaborative research projects on biomedical research between clinicians and researchers who have not previously worked together and who are based in different research institutions. Priority will be given to projects that are novel and innovative, that are establishing new collaborations within Luxembourg and where preliminary data is needed prior to submitting an application to an external funding agency.

The main expected return on investment of such funding relies on:

  • Ÿ Solving unmet clinical needs with innovative approach
  • Ÿ Fostering research interactions between the 3 biomedical research institutes of Luxembourg.
  • Ÿ Enabling researchers/clinicians to develop this project into an externally funding project if successful

For full details about the call, the conditions of eligibility and the application process, you can download the PMC FUND Overview & Guidelines. If you wish to apply, you can download the PMC FUND Application Form.

Call deadline:  The call is open from 1st September 2014. All application forms should be completed and submitted to by 15th October 2014.

Contact: If you have any question about the PMC Fund, please contact Angela HOGAN:

Tel:  +352 27 44 64 42